CN101703597A - Medicament for treating rhinitis - Google Patents
Medicament for treating rhinitis Download PDFInfo
- Publication number
- CN101703597A CN101703597A CN200910230319A CN200910230319A CN101703597A CN 101703597 A CN101703597 A CN 101703597A CN 200910230319 A CN200910230319 A CN 200910230319A CN 200910230319 A CN200910230319 A CN 200910230319A CN 101703597 A CN101703597 A CN 101703597A
- Authority
- CN
- China
- Prior art keywords
- fructus
- medicine
- parts
- radix angelicae
- rhinitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 29
- 206010039083 rhinitis Diseases 0.000 title claims abstract description 27
- 241000931705 Cicada Species 0.000 claims abstract description 5
- 241000628997 Flos Species 0.000 claims description 26
- 239000009670 cang er zi wan Substances 0.000 claims description 12
- 239000006071 cream Substances 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 241000202807 Glycyrrhiza Species 0.000 claims description 4
- 241000545442 Radix Species 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 8
- 235000013399 edible fruits Nutrition 0.000 abstract 3
- 241000213006 Angelica dahurica Species 0.000 abstract 2
- 235000007516 Chrysanthemum Nutrition 0.000 abstract 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract 1
- 241000218378 Magnolia Species 0.000 abstract 1
- 240000006079 Schisandra chinensis Species 0.000 abstract 1
- 241000951473 Schizonepeta Species 0.000 abstract 1
- 235000008216 herbs Nutrition 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 239000000796 flavoring agent Substances 0.000 description 9
- 235000019634 flavors Nutrition 0.000 description 9
- 230000028327 secretion Effects 0.000 description 8
- 206010028748 Nasal obstruction Diseases 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 6
- 210000002850 nasal mucosa Anatomy 0.000 description 5
- 210000001331 nose Anatomy 0.000 description 5
- 210000004379 membrane Anatomy 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 210000003097 mucus Anatomy 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- 206010039101 Rhinorrhoea Diseases 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 210000003928 nasal cavity Anatomy 0.000 description 3
- 208000010753 nasal discharge Diseases 0.000 description 3
- 201000009240 nasopharyngitis Diseases 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 2
- 206010020565 Hyperaemia Diseases 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 201000009151 chronic rhinitis Diseases 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000001969 hypertrophic effect Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 201000009890 sinusitis Diseases 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 201000008283 Atrophic Rhinitis Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000158526 Nasalis Species 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 206010061926 Purulence Diseases 0.000 description 1
- 206010039085 Rhinitis allergic Diseases 0.000 description 1
- 206010039088 Rhinitis atrophic Diseases 0.000 description 1
- 208000036284 Rhinitis seasonal Diseases 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 201000010105 allergic rhinitis Diseases 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 210000004081 cilia Anatomy 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 235000019600 saltiness Nutrition 0.000 description 1
- 230000003393 splenic effect Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 210000001944 turbinate Anatomy 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a medicament for treating rhinitis, which belongs to the technical field of medicament making, which is prepared from the following raw materials in proportion: biond magnolia flower, siberian cocklour fruit, cicada slough, Chinese angelica, Chinese magnoliavine fruit, liquoric root, dark plum fruit, fineleaf schizonepeta herb, dahurian angelica root and chrysanthemum. The medicament is prepared by adopting pure Chinese medicinal herbs, has no toxic or side effect, frees lung-qi and promotes the restoration of consciousness, dispels the wind and removes dampness, and has the good curative effect on the rhinitis.
Description
Technical field
The present invention relates to medicine pharmaceutical technology field, specifically a kind of medicine for the treatment of rhinitis.
Background technology
Rhinitis refers to the inflammation of nasal membrane and submucous tissue.Show as hyperemia or edema, the patient nasal obstruction occurs through regular meeting, stream clear water tears, rhinocnesmus, sneeze, headache, giddy, throat's discomfort, symptoms such as cough.The performance of rhinitis is varied, from the pathological change of nasal membrane, chronic simple rhinitis, chronic hypertrophic rhinitis, caseous rhinitis, atrophic rhinitis etc. is arranged, and from the slow length that reaches the course of disease of the urgency of morbidity, chronic rhinitis and acute rhinitis is arranged.Method for the treatment rhinitis typically uses antibiotic, but after the antibiotic use for a long time, the pathogenic bacteria of nasal cavity is developed immunity to drugs, so that curative effect is bad.
Summary of the invention
A kind of medicine for the treatment of rhinitis that the objective of the invention is to disclose evident in efficacy, taking convenience and be free from side effects.
Traditional Chinese medical science treatment of rhinitis theory is thought: rhinitis, sinusitis be plain body surface void, weakened defensive QI, again feel ailment said due to cold or exposure, go in due to the heat-transformation, YIN-cold nose key, impairment of dispersing and descending function of the lung.Its key is deficiency of both the splenic and pulmonary QI, and insufficiency of lung-QI is subject to exopathogen, as experiencing wind heat repeatedly so that wind heat is loved lung, on disturb the nose key, the cold obstructed or emptiness of spleen and stomach of nose then, gas is not declared logical, QI-blood circulation is not all right, feels wind and cold again, makes coagulation of QI-blood, it is obstructed then to have a stuffy nose.Emptiness of spleen and stomach, water is wet to be contained partially, feels wind and cold again, and water wets coldly and coagulates, and the poly-nose key of turbid damp knot then produces nasal obstruction watery nasal discharge formation rhinitis.Therefore how with strengthening vital QI to eliminate pathogenic factors, lung qi dispersing is sensible clinically for the traditional Chinese medical science, and expelling wind and clearing away heat is main.According to the Chinese medicine theory, the present invention adopts seed of Flos Magnoliae Liliflorae, Fructus Xanthii, Periostracum Cicadae, Radix Angelicae Sinensis, Fructus Schisandrae Chinensis, Radix Glycyrrhizae, Fructus Mume, Herba Schizonepetae, the Radix Angelicae Dahuricae and Flos Chrysanthemi, and is formulated by science compatibility and preparation method.
This medicine of the present invention is that the one-tenth by following weight portion proportioning is grouped into:
Seed of Flos Magnoliae Liliflorae 100-300 part Fructus Xanthii 100-200 part Periostracum Cicadae 100-200 part
Radix Angelicae Sinensis 20-200 part Fructus Schisandrae Chinensis 100-200 part Radix Glycyrrhizae 100-200 part
Fructus Mume 10-200 part Herba Schizonepetae 100-250 part Radix Angelicae Dahuricae 100-300 part
Flos Chrysanthemi 100-300 part,
The preparation method of this medicine is as follows:
(1) seed of Flos Magnoliae Liliflorae, Fructus Mume are smash into broken end;
(2) the broken end in the step (1) and Radix Angelicae Sinensis, Fructus Schisandrae Chinensis, Flos Chrysanthemi, the Radix Angelicae Dahuricae, Radix Glycyrrhizae, Herba Schizonepetae are mixed, decoct with water 1-3 time, filtered and recycled, extracting juice is concentrated into thickness cream;
(3) Fructus Xanthii, Periostracum Cicadae grind into powder;
(4) again the powder in the step (3) is mixed with thickness cream in the step (2), stir; Be made into capsule or tablet.
The pharmacology of medicine of the present invention and the property of medicine:
Periostracum Cicadae: nature and flavor, sweet in the mouth, saltiness cold.Function, dispelling wind and heat pathogens, rash are antipruritic, removing nebula to improve visual acuity, expelling wind to relieve convulsion.
This medicine is that the one-tenth by following weight portion proportioning is grouped into:
Seed of Flos Magnoliae Liliflorae 120-280 part Fructus Xanthii 120-180 part Periostracum Cicadae 120-190 part
Radix Angelicae Sinensis 50-180 part Fructus Schisandrae Chinensis 120-180 part Radix Glycyrrhizae 120-180 part
Fructus Mume 40-180 part Herba Schizonepetae 120-200 part Radix Angelicae Dahuricae 120-250 part
Flos Chrysanthemi 120-250 part.
This medicine is that the one-tenth by following weight portion proportioning is grouped into:
180 parts of 140 portions of Periostracum Cicadaes of 180 portions of Fructus Xanthii of seed of Flos Magnoliae Liliflorae
140 parts in 140 portions of Radix Glycyrrhizaes of 140 parts of Fructus Schisandrae Chinensis of Radix Angelicae Sinensis
180 parts of 140 parts of Radixs Angelicae Dahuricae of 140 portions of Herba Schizonepetae of Fructus Mume
180 parts of Flos Chrysanthemis.
This ingredient property of medicine is as follows:
Flos Chrysanthemi: nature and flavor are bitter, be slightly cold.Function, clearing away heat to dispel wind, suppressing the hyperactive liver makes eye bright.
Herba Schizonepetae: nature and flavor, hot, tepor.Function, relieving the exterior syndrome by diaphoresis; The treating blood disorders detoxifcation.
Flos Magnoliae: nature and flavor, hot, warm.Function, logical lung key is the different special medicine of treatment nasal obstruction.
Radix Glycyrrhizae: nature and flavor, sweet, flat.Function, invigorating the heart and spleen; Nourishing the lung to arrest cough; Eliminating fire and detoxication.
The Radix Angelicae Dahuricae: nature and flavor, hot, warm.Function, the wind dehumidifying of loosing; Awakening consciousness is used for rhinitis, sinusitis, detumescence and apocenosis.
Fructus Schisandrae Chinensis: nature and flavor are sour, sweet; Temperature.Function, restrain astringent or styptic treatment for spontaneous sweating, supplementing QI for promoting the production of body fluid, kidney calming.
Fructus Mume: nature and flavor are sour, warm.Function, the astringing intestine to stop diarrhea of astringing the lung ends chronic cough expectorant, can suppress noxious bacteria.
Radix Angelicae Sinensis: nature and flavor, Gan Xin, temperature.The effect of effect profitization blood is used for the uncomfortable disease of painstaking effort.
The invention has the beneficial effects as follows: preparation is simple, and taking convenience has no side effect, but awakening consciousness, clearing away heat to dispel wind can be eliminated hyperemia and edema, and the acute rhinitis that multiple reason is caused, chronic rhinitis etc. all have curative effect preferably.
The specific embodiment
Embodiment 1:
1, prescription
160 parts of 160 portions of Periostracum Cicadaes of 180 portions of Fructus Xanthii of seed of Flos Magnoliae Liliflorae
140 parts in 160 portions of Radix Glycyrrhizaes of 150 parts of Fructus Schisandrae Chinensis of Radix Angelicae Sinensis
180 parts of 140 parts of Radixs Angelicae Dahuricae of 120 portions of Herba Schizonepetae of Fructus Mume
160 parts of Flos Chrysanthemis,
2, preparation method
(1) seed of Flos Magnoliae Liliflorae, Fructus Mume are smash into broken end;
(2) the broken end in the step (1) and Radix Angelicae Sinensis, Fructus Schisandrae Chinensis, Flos Chrysanthemi, the Radix Angelicae Dahuricae, Radix Glycyrrhizae, Herba Schizonepetae are mixed, decoct with water 1-3 time, filtered and recycled, extracting juice is concentrated into thickness cream;
(3) Fructus Xanthii, Periostracum Cicadae, grind into powder;
(4) again the powder in the step (3) is mixed with thickness cream in the step (2), stir; Be made into capsule or tablet, drying, promptly.
Embodiment 2:
1, prescription
140 parts of 150 portions of Periostracum Cicadaes of 190 portions of Fructus Xanthii of seed of Flos Magnoliae Liliflorae
130 parts in 130 portions of Radix Glycyrrhizaes of 120 parts of Fructus Schisandrae Chinensis of Radix Angelicae Sinensis
160 parts of 160 parts of Radixs Angelicae Dahuricae of 160 portions of Herba Schizonepetae of Fructus Mume
140 parts of Flos Chrysanthemis,
2, preparation method is identical with embodiment 1.
3, therapeutic effect: use Drug therapy 560 examples of above-mentioned treatment rhinitis, male 380 people, women 180 people cure 498 examples (88.9%), produce effects 43 examples (7.7%), effective 11 examples (2.0%), invalid 8 examples (1.4%) total effective rate is 98.6%.Be exemplified below:
The Qin *, the man suffers from acute rhinitis, the many situations of nasal obstruction and secretions often occur, and mucus purulence nasal mucus appears in secretions.The congested swelling of its nasal mucosa on inspection has secretions.Take this medicine after 10 days, secretions disappears, and breathes unobstructed.
The field * *, its symptom is a nasal obstruction, and the lighter is intermittent or property alternately, and weight person is a persistence, and nasal discharge increases.The congested swelling of nasal mucosa is seen in inspection, and nasal meatus has a small amount of mucus secretions, and serious hypertrophic rhinitis is owing to hamartoplasia, and mucomembranous surface is uneven, and concha nasalis inferior is the Fructus Mori shape to be changed, and the middle nasal concha mucosa is polypoid and becomes.After taking for 2 weeks, above-mentioned symptom is eliminated substantially, breathes smooth and easy.
The king * *, suffer from allergic rhinitis, nasal membrane is extremely sensitive to sucking airborne some composition, internal energy morbidity on the one repeatedly, health is extremely uncomfortable during morbidity.Use this medicine after 4 days, the number of times of falling ill every day reduces, after the week, and transference cure.
Open *, certain worker of enterprise because the work cause, the long-term irriate of nasal mucosa and the atrophy of mucus body of gland takes place, secretions reduces, the mucosa drying.Use this medicine after 15 days, transference cure, nasal membrane are no longer dry.
Lee *, suffer from the seasonal rhinitis, nose is relatively poor to this climate change adaptive capacity that colds and heat succeed each other too fast, is not also adapting under the situation of cold air state of an illness outbreak; Use this medicine after one week, transference cure.
Korea Spro * *, suffer from the rhinitis initial stage, use incorrect nasal cavity medicine, and anxious because of its treatment, use amount is excessive, with induced damage resistive the structure of nasal mucosa cilium, influenced the physiological function of nasal mucosa.
The Meng *, nasal obstruction, stuffiness, nasal cavity secretions is more.After taking 5, secretions disappears, and breathes unimpeded.
Liu * *, nasal obstruction, watery nasal discharge is regularly felt dizzy, headache; After taking 4, aforementioned transference cure.
Claims (3)
1. medicine for the treatment of rhinitis is characterized in that this medicine is that one-tenth by following weight portion proportioning is grouped into:
Seed of Flos Magnoliae Liliflorae 100-300 part Fructus Xanthii 100-200 part Periostracum Cicadae 100-200 part
Radix Angelicae Sinensis 20-200 part Fructus Schisandrae Chinensis 100-200 part Radix Glycyrrhizae 100-200 part
Fructus Mume 10-200 part Herba Schizonepetae 100-250 part Radix Angelicae Dahuricae 100-300 part
Flos Chrysanthemi 100-300 part,
The preparation method step is as follows:
(1) seed of Flos Magnoliae Liliflorae, Fructus Mume are smash into broken end;
(2) the broken end in the step (1) and Radix Angelicae Sinensis, Fructus Schisandrae Chinensis, Flos Chrysanthemi, the Radix Angelicae Dahuricae, Radix Glycyrrhizae, Herba Schizonepetae are mixed, decoct with water 1-3 time, filtered and recycled, extracting juice is concentrated into thickness cream;
(3) Fructus Xanthii, Periostracum Cicadae grind into powder;
(4) again the powder in the step (3) is mixed with thickness cream in the step (2), stir, be made into capsule, tablet.
2. a kind of medicine for the treatment of rhinitis according to claim 1 is characterized in that this medicine is that one-tenth by following weight portion proportioning is grouped into:
Seed of Flos Magnoliae Liliflorae 120-280 part Fructus Xanthii 120-180 part Periostracum Cicadae 120-190 part
Radix Angelicae Sinensis 50-180 part Fructus Schisandrae Chinensis 120-180 part Radix Glycyrrhizae 120-180 part
Fructus Mume 40-180 part Herba Schizonepetae 120-200 part Radix Angelicae Dahuricae 120-250 part
Flos Chrysanthemi 120-250 part.
3. a kind of medicine for the treatment of rhinitis according to claim 1 is characterized in that this medicine is that one-tenth by following weight portion proportioning is grouped into:
180 parts of 140 portions of Periostracum Cicadaes of 180 portions of Fructus Xanthii of seed of Flos Magnoliae Liliflorae
140 parts in 140 portions of Radix Glycyrrhizaes of 140 parts of Fructus Schisandrae Chinensis of Radix Angelicae Sinensis
180 parts of 140 parts of Radixs Angelicae Dahuricae of 140 portions of Herba Schizonepetae of Fructus Mume
180 parts of Flos Chrysanthemis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102303192A CN101703597B (en) | 2009-11-10 | 2009-11-10 | Medicament for treating rhinitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102303192A CN101703597B (en) | 2009-11-10 | 2009-11-10 | Medicament for treating rhinitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101703597A true CN101703597A (en) | 2010-05-12 |
| CN101703597B CN101703597B (en) | 2011-08-10 |
Family
ID=42373894
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009102303192A Expired - Fee Related CN101703597B (en) | 2009-11-10 | 2009-11-10 | Medicament for treating rhinitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101703597B (en) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102225116A (en) * | 2011-06-02 | 2011-10-26 | 长治市郊区黄碾镇中心卫生院 | Medicine for treating rhinitis and preparation method thereof |
| CN102228541A (en) * | 2011-06-30 | 2011-11-02 | 万京明 | Chinese medicinal preparation for treating chronic rhinosinusitis |
| CN102526546A (en) * | 2012-01-04 | 2012-07-04 | 田胜利 | Chinese medicinal composition and preparation and preparation method thereof |
| CN102895528A (en) * | 2012-10-26 | 2013-01-30 | 江志鑫 | Traditional Chinese medicine for treatment of spleen/lung qi-deficiency type allergic rhinitis and preparation method thereof |
| CN103735707A (en) * | 2013-12-30 | 2014-04-23 | 冯大祥 | Traditional Chinese medicine for treating rhinitis |
| CN103830522A (en) * | 2013-12-06 | 2014-06-04 | 济南新起点医药科技有限公司 | Traditional Chinese medicine composition for treating rhinitis |
| CN104189081A (en) * | 2014-07-22 | 2014-12-10 | 江苏康缘药业股份有限公司 | Traditional Chinese medicine composition for treating allergic rhinitis and preparation method thereof |
| CN104688898A (en) * | 2015-04-02 | 2015-06-10 | 朱克兰 | Foot bath composition for treating anaphylactic rhinitis and preparation method thereof |
| CN113648383A (en) * | 2019-10-16 | 2021-11-16 | 徐鑫 | Traditional Chinese medicine composition for treating allergic rhinitis and nasosinusitis and preparation method and application of traditional Chinese medicine composition powder |
-
2009
- 2009-11-10 CN CN2009102303192A patent/CN101703597B/en not_active Expired - Fee Related
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102225116A (en) * | 2011-06-02 | 2011-10-26 | 长治市郊区黄碾镇中心卫生院 | Medicine for treating rhinitis and preparation method thereof |
| CN102228541A (en) * | 2011-06-30 | 2011-11-02 | 万京明 | Chinese medicinal preparation for treating chronic rhinosinusitis |
| CN102526546A (en) * | 2012-01-04 | 2012-07-04 | 田胜利 | Chinese medicinal composition and preparation and preparation method thereof |
| CN102895528A (en) * | 2012-10-26 | 2013-01-30 | 江志鑫 | Traditional Chinese medicine for treatment of spleen/lung qi-deficiency type allergic rhinitis and preparation method thereof |
| CN103830522A (en) * | 2013-12-06 | 2014-06-04 | 济南新起点医药科技有限公司 | Traditional Chinese medicine composition for treating rhinitis |
| CN103735707A (en) * | 2013-12-30 | 2014-04-23 | 冯大祥 | Traditional Chinese medicine for treating rhinitis |
| CN104189081A (en) * | 2014-07-22 | 2014-12-10 | 江苏康缘药业股份有限公司 | Traditional Chinese medicine composition for treating allergic rhinitis and preparation method thereof |
| CN104189081B (en) * | 2014-07-22 | 2018-01-12 | 江苏康缘药业股份有限公司 | It is a kind of to be used to treat Chinese medicine composition of allergic rhinitis and preparation method thereof |
| CN104688898A (en) * | 2015-04-02 | 2015-06-10 | 朱克兰 | Foot bath composition for treating anaphylactic rhinitis and preparation method thereof |
| CN113648383A (en) * | 2019-10-16 | 2021-11-16 | 徐鑫 | Traditional Chinese medicine composition for treating allergic rhinitis and nasosinusitis and preparation method and application of traditional Chinese medicine composition powder |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101703597B (en) | 2011-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101703597B (en) | Medicament for treating rhinitis | |
| CN103330886B (en) | Traditional Chinese medicine composition for treating chronic pharyngitis | |
| CN103920106A (en) | Traditional Chinese medicinal composition for treating bronchitis and bronchial asthma | |
| CN102813702A (en) | Lotion for treating rhinitis | |
| CN103463416A (en) | Traditional Chinese medicine preparation for treating rhinitis and pharyngitis | |
| CN103536889B (en) | One is treated senile chronic tracheitis and is merged emophysematous Chinese medicine decoction | |
| CN101502614B (en) | Medicine tea for stopping snore | |
| CN101524497A (en) | Chinese medicinal preparation for treating pharyngitis | |
| CN103584598B (en) | A kind of Chinese medicinal pillow for the treatment of rhinitis chronic | |
| CN103330826B (en) | Traditional Chinese medicine composition for treating deficiency of lung yin | |
| CN104208483A (en) | Traditional Chinese medicine composition for treating anaphylactic rhinitis | |
| CN105497486A (en) | Traditional Chinese medicine composition for treating chronic rhinitis | |
| CN101703688A (en) | Chinese medicinal composition for treating chronic pharyngitis | |
| CN103638512A (en) | Traditional Chinese medicine for treating acute bronchitis and preparation method thereof | |
| CN103330814B (en) | A kind of Chinese medicine composition for the treatment of insufficiency of kidney-YANG | |
| CN102302688B (en) | Traditional Chinese medicine used for treating influenza caused by damp toxin, and preparation method thereof | |
| CN101543590A (en) | Chinese medicinal composition for treating chronic pharyngitis and preparation method thereof | |
| CN104873862A (en) | Traditional Chinese medicine composition for treating chronic pharyngitis | |
| CN104107344A (en) | Traditional Chinese medicine composition for treating chronic bronchitis | |
| CN104606650A (en) | Traditional Chinese medicine composition treating insomnia | |
| CN102579772A (en) | Preparation method of Chinese medicinal lotion for treating chronic ulcer of shank with phlegm turbidity and obstruction syndrome | |
| CN103251701B (en) | Traditional Chinese medicine composition for treating rhinitis | |
| CN102138977A (en) | Baizhi Xiner decoction for adenoid vegetation | |
| CN105748906A (en) | Medicinal tea for treating chronic pharyngitis and preparation method of medicinal tea | |
| CN105381125B (en) | Traditional Chinese medicine composition for preventing and treating influenza as well as preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: DONG RUIQIAN Free format text: FORMER OWNER: KAN GONGYONG Effective date: 20110518 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Dong Ruiqian Inventor before: Han Gongyong |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: KAN GONGYONG TO: DONG RUIQIAN Free format text: CORRECT: ADDRESS; FROM: 250014 NO. 2-43, YAOTOU ROAD, LIXIA DISTRICT, JI NAN CITY, SHANDONG PROVINCE TO: 250001 JI NAN MATERNITY AND CHILD CARE HOSPITAL, NO. 2, JIANGUO XIAOJING 3RD ROAD, JI NAN CITY, SHANDONG PROVINCE |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20110518 Address after: 250001 Ji'nan maternal and child health care hospital, No. three, No. 2, Jianguo Road, Ji'nan, Shandong Applicant after: Dong Ruiqian Address before: 250014 Shandong Province, Lixia District of Ji'nan City Kiln Road No. 2-43 Applicant before: Han Gongyong |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110810 Termination date: 20121110 |